Tissue Engineering Program and Surgical Research
Tai Yi has not added Biography.
If you are Tai Yi and would like to personalize this page please email our Author Liaison for assistance.
Tropoelastin inhibits intimal hyperplasia of mouse bioresorbable arterial vascular grafts.
Acta biomaterialia 04, 2017 | Pubmed ID: 28025048
Benchmark dose approach for renal dysfunction in workers exposed to lead.
Environmental toxicology Jun, 2007 | Pubmed ID: 17497640
Application of benchmark dose for occupational epidemiology in lead exposure.
Toxicology mechanisms and methods , 2008 | Pubmed ID: 20020903
Characterization of ambient air quality during a rice straw burning episode.
Journal of environmental monitoring : JEM Mar, 2012 | Pubmed ID: 22245854
Role of HO-1 in the arsenite-induced neurotoxicity in primary cultured cortical neurons.
Molecular neurobiology Oct, 2013 | Pubmed ID: 23824679
Characterization of evolving biomechanical properties of tissue engineered vascular grafts in the arterial circulation.
Journal of biomechanics Jun, 2014 | Pubmed ID: 24702863
Evaluation of remodeling process in small-diameter cell-free tissue-engineered arterial graft.
Journal of vascular surgery Apr, 2014 | Pubmed ID: 24745941
Comparison of the biological equivalence of two methods for isolating bone marrow mononuclear cells for fabricating tissue-engineered vascular grafts.
Tissue engineering. Part C, Methods Jun, 2015 | Pubmed ID: 25397868
Well-organized neointima of large-pore poly(L-lactic acid) vascular graft coated with poly(L-lactic-co-ε-caprolactone) prevents calcific deposition compared to small-pore electrospun poly(L-lactic acid) graft in a mouse aortic implantation model.
Atherosclerosis Dec, 2014 | Pubmed ID: 25463106
Biomechanical diversity despite mechanobiological stability in tissue engineered vascular grafts two years post-implantation.
Tissue engineering. Part A May, 2015 | Pubmed ID: 25710791
The innate immune system contributes to tissue-engineered vascular graft performance.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology Jun, 2015 | Pubmed ID: 25713026
Development of small diameter nanofiber tissue engineered arterial grafts.
PloS one , 2015 | Pubmed ID: 25830942
Hemodynamic Characterization of a Mouse Model for Investigating the Cellular and Molecular Mechanisms of Neotissue Formation in Tissue-Engineered Heart Valves.
Tissue engineering. Part C, Methods Sep, 2015 | Pubmed ID: 25915105
Cilostazol, Not Aspirin, Prevents Stenosis of Bioresorbable Vascular Grafts in a Venous Model.
Arteriosclerosis, thrombosis, and vascular biology Sep, 2015 | Pubmed ID: 26183618
A mouse model of endocardial fibroelastosis.
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology Nov-Dec, 2015 | Pubmed ID: 26363814
Interferon-γ-mediated allograft rejection exacerbates cardiovascular disease of hyperlipidemic murine transplant recipients.
Circulation research Nov, 2015 | Pubmed ID: 26399469
Long-Term Functional Efficacy of a Novel Electrospun Poly(Glycerol Sebacate)-Based Arterial Graft in Mice.
Annals of biomedical engineering 08, 2016 | Pubmed ID: 26795977
Rational design of an improved tissue-engineered vascular graft: determining the optimal cell dose and incubation time.
Regenerative medicine Mar, 2016 | Pubmed ID: 26925512
TGF-β receptor 1 inhibition prevents stenosis of tissue-engineered vascular grafts by reducing host mononuclear phagocyte activation.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology Jul, 2016 | Pubmed ID: 27059717
Novel Bioresorbable Vascular Graft With Sponge-Type Scaffold as a Small-Diameter Arterial Graft.
The Annals of thoracic surgery Sep, 2016 | Pubmed ID: 27154152
Pilot Mouse Study of 1 mm Inner Diameter (ID) Vascular Graft Using Electrospun Poly(ester urea) Nanofibers.
Advanced healthcare materials 09, 2016 | Pubmed ID: 27390286
Tissue-Engineered Small Diameter Arterial Vascular Grafts from Cell-Free Nanofiber PCL/Chitosan Scaffolds in a Sheep Model.
PloS one , 2016 | Pubmed ID: 27467821
Engineered Tissue-Stent Biocomposites as Tracheal Replacements.
Tissue engineering. Part A Sep, 2016 | Pubmed ID: 27520928
Fast-degrading bioresorbable arterial vascular graft with high cellular infiltration inhibits calcification of the graft.
Journal of vascular surgery 07, 2017 | Pubmed ID: 27687327
Role of Bone Marrow Mononuclear Cell Seeding for Nanofiber Vascular Grafts.
Tissue engineering. Part A Jun, 2017 | Pubmed ID: 28486019
The role of myeloid cell-derived PDGF-B in neotissue formation in a tissue-engineered vascular graft.
Regenerative medicine 04, 2017 | Pubmed ID: 28524773
Deconstructing the Tissue Engineered Vascular Graft: Evaluating Scaffold Pre-Wetting, Conditioned Media Incubation, and Determining the Optimal Mononuclear Cell Source.
ACS biomaterials science & engineering , 2017 | Pubmed ID: 29226239
Intratumoral Delivery of Interferonγ-Secreting Mesenchymal Stromal Cells Repolarizes Tumor-Associated Macrophages and Suppresses Neuroblastoma Proliferation In Vivo.
Stem cells (Dayton, Ohio) 06, 2018 | Pubmed ID: 29430789
Oversized Biodegradable Arterial Grafts Promote Enhanced Neointimal Tissue Formation.
Tissue engineering. Part A Aug, 2018 | Pubmed ID: 29431029
Bone marrow-derived mononuclear cell seeded bioresorbable vascular graft improves acute graft patency by inhibiting thrombus formation via platelet adhesion.
International journal of cardiology Sep, 2018 | Pubmed ID: 29887474
Angiotensin II receptor I blockade prevents stenosis of tissue engineered vascular grafts.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology Jun, 2018 | Pubmed ID: 29906242
Immuno-driven and Mechano-mediated Neotissue Formation in Tissue Engineered Vascular Grafts.
Annals of biomedical engineering Nov, 2018 | Pubmed ID: 29987541
Implantation of VEGF-functionalized cell-free vascular grafts: regenerative and immunological response.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 04, 2019 | Pubmed ID: 30629890
Early natural history of neotissue formation in tissue-engineered vascular grafts in a murine model.
Regenerative medicine 05, 2019 | Pubmed ID: 31180275
Differential outcomes of venous and arterial tissue engineered vascular grafts highlight the importance of coupling long-term implantation studies with computational modeling.
Acta biomaterialia 08, 2019 | Pubmed ID: 31200116
Degradation and evaluation of polycaprolactone, poly(ε-caprolactone-co-L-lactide), and poly-L-lactic acid as scaffold sealant polymers for murine tissue-engineered vascular grafts.
Regenerative medicine 07, 2019 | Pubmed ID: 31342857
Different degradation rates of nanofiber vascular grafts in small and large animal models.
Journal of tissue engineering and regenerative medicine 02, 2020 | Pubmed ID: 31756767
Fetal Transcatheter Trileaflet Heart Valve Hemodynamics: Implications of Scaling on Valve Mechanics and Turbulence.
Annals of biomedical engineering Jun, 2020 | Pubmed ID: 32052320
Electrospun Tissue-Engineered Arterial Graft Thickness Affects Long-Term Composition and Mechanics.
Tissue engineering. Part A 05, 2021 | Pubmed ID: 32854586
Effects of Braiding Parameters on Tissue Engineered Vascular Graft Development.
Advanced healthcare materials 12, 2020 | Pubmed ID: 33063452
Tissue Engineered Vascular Graft Recipient Interleukin 10 Status Is Critical for Preventing Thrombosis.
Advanced healthcare materials 12, 2020 | Pubmed ID: 33073543
Sex and Tamoxifen confound murine experimental studies in cardiovascular tissue engineering.
Scientific reports Apr, 2021 | Pubmed ID: 33850181
Imatinib attenuates neotissue formation during vascular remodeling in an arterial bioresorbable vascular graft.
JVS-vascular science , 2020 | Pubmed ID: 34223286
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados